Search
Should You Go For This Mid Cap US Company-PATH
| Acrobull Canada Advisory Inc. |
April 10 | 2026 | ||||
| Name | Ticker | Sector/Industry | Market Cap | Risk Factor | |
UIPATH, Inc. | PATH-NYSE | Technology | $5.31 Billion | Medium | |
UiPath Inc. is a leading enterprise automation and artificial intelligence software company that specializes in robotic process automation (RPA). The company provides a comprehensive platform that enables organizations to automate repetitive business processes using AI-driven software robots.
Its platform integrates AI, machine learning, and analytics to enhance productivity across industries such as finance, healthcare, and logistics. UiPath is widely recognized as one of the pioneers in enterprise automation and continues to expand into generative AI and intelligent automation solutions.
Recent Highlights
|
| Fourth Quarter 2026 Financial Highlights |
| Stock Observation- The stock is currently trading near its 52-week low, well below its historical highs of over $80, as market sentiment has weakened amid slowing enterprise software spending, intensifying competition in automation and AI, and a broader shift from growth to profitability; however, the long-term outlook remains positive thanks to the company's strong positioning in AI, rising demand for automation, and ongoing enterprise digital transformation trends. |
|
Risk Involved- Financial performance of the company may have an impact on the company stock performance. |
| Considering all the factors and financials of the company Acrobull Canada Advisory Inc. maintains Customer Choose Buy for the stock. |
Disclaimer- Though our research is fundamentally and technically based on Acrobull Canada Advisory Inc. only provides general advice on the stocks and it is imperative for the investors to do the risk assessment for themselves before investing as Acrobull Canada Advisory Inc. would not be liable for any loss or profit arising out through the investment made by the investors on our recommendations. It is also advisable for the investors to consult with Financial Advisor, Broker or to seek any legal assistance as the research conducted by Acrobull Canada Advisory Inc. Inc ltd. is factually based and recommendations are given in accordance with that, but it is imperative to understand that Acrobull Canada Advisory Inc. does not guarantee returns. |
Acrobull Recommendation Based on Evaluation
| Current Market Price | $9.94 USD |
| Acrobull Recommendation | Buy |
| Target Price | $11.90 USD |
| RSI Level | 40–45 (Neutral, near oversold) |
| Total Shares Outstanding | 460 million |
Shares held by Insiders Shares Held By Institutional Investors Risk Factor Stop Loss | 9.44% 81% Medium 5% |
© Copyright Acro Bull UK All Rights Reserved 2026